Skip to main content
Equibles

ALPS ADVISORS INC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1376113 Denver, CO
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$430,226
+$340,488 QoQ
Shares Held
29,508
+81.5% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 122 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. ENTA ranks #96 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 315,335 $17,680,833
2 APGE
Apogee Therapeutics, Inc.
 62,523 $8,298,677
3 CGON
CG Oncology, Inc.
 89,218 $6,338,938
4 XENE
Xenon Pharmaceuticals Inc.
 97,610 $5,891,739
5 ORKA
Oruka Therapeutics, Inc.
 61,014 $5,806,702
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 55,281 $5,388,791
7 TVTX
Travere Therapeutics, Inc.
 93,981 $5,339,060
8 DFTX
Definium Therapeutics, Inc.
 110,388 $5,192,651

All Filings in ENTA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $430,226 29,508
2025-03-31 $89,738 16,257
2024-12-31 $98,537 17,137
2024-09-30 $166,153 16,038
2024-06-30 $214,290 16,522
2024-03-31 $260,503 14,920
2023-12-31 $137,395 14,601
2023-09-30 $173,101 15,497
2023-06-30 $331,186 15,476
2023-03-31 $556,413 13,759
2022-12-31 $654,955 14,079
2022-09-30 $585,352 11,285
2022-06-30 $580,806 12,287
2022-03-31 $1,502,111 21,103
2021-12-31 $1,758,900 23,521
2021-09-30 $1,407,240 24,771
2021-06-30 $1,170,533 26,597
2021-03-31 $1,791,499 36,324
2020-12-31 $1,527,893 36,292
2020-09-30 $1,171,739 25,595
2020-06-30 $1,369,979 27,285
2020-03-31 $1,844,588 35,866